共 21 条
[11]
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guerin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
[J].
EUROPEAN UROLOGY,
2013, 63 (03)
:462-472
[20]
WHO and Patient Safety, 2009, IMPL MAN WHO SURG SA